Biogen looks at selling biosims unit to longtime ally Samsung Bioepis: reports

During a first-quarter earnings call, as CEO Chris Viehbacher talked of his plan to return Biogen to growth, he said the company needed to figure out the best way to manage its biosimilar business and determine who might be its “best owner.”